Chronic effects of a novel synthetic anthracycline derivative (SM-5887) on normal heart and doxorubicin-induced cardiomyopathy in beagle dogs

A clinicopathologic analysis of adriamycin cardiotoxicity

1973 • 1,534 citations

Anthracycline cardiomyopathy monitored by morphologic changes.

1978 • 589 citations

Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats.

1977 • 166 citations

Comparison of the effectiveness of (+/-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) and N-acetylcysteine in preventing chronic doxorubicin cardiotoxicity in beagles.

1985 • 119 citations

Antitumor Activities of a Novel 9‐Aminoanthracycline (SM‐5887) against Mouse Experimental Tumors and Human Tumor Xenografts

1989 • 83 citations

Quantitative experimental evaluation of adriamycin cardiotoxicity in the mouse.

1979 • 74 citations

Chronic cardiotoxicity of doxorubicin (Adriamycin) in the rat: Morphologic and biochemical investigations

1978 • 68 citations

Reduction of chronic daunorubicin cardiotoxicity by ICRF-187 in rabbits.

1981 • 59 citations

The dosing schedule dependent toxicities of adriamycin in beagle dogs and rhesus monkeys

1979 • 44 citations

Therapeutic response of human tumor xenografts in athymic mice to doxorubicin.

1981 • 38 citations

Evaluation of response rates to various antitumor agents of human gastric tumors implanted in nude mouse.

1986 • 31 citations

Toxicological Aspects of a Novel 9‐Aminoanthracycline, SM‐5887

1989 • 29 citations

The effect of mitoxantrone treatment in beagle dogs previously treated with minimally cardiotoxic doses of doxorubicin.

1987 • 12 citations

Reduction of chronic doxorubicin cardiotoxicity in beagle dogs by bis-morpholinomethyl derivative of razoxane (ICRF-159)

1987 • 11 citations

Cardiac toxicity and antitumor activity of 4′-deoxy-4′-iodo-doxorubicinol

1990 • 7 citations